PDGFRA and central nervous system cancer: The transmembrane receptor PDGFRA is overexpressed, amplified, mutated, or truncated in gliomas and is the second most frequently mutated tyrosine kinase receptor in glioblastomas (Alentorn et al., 2012; Higa et al., 2022).